Corbus Pharmaceuticals Holdings, Inc. Gain (Loss) on Extinguishment of Debt
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Gain (Loss) on Extinguishment of Debt of $0 for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2016-03-28
- Corbus Pharmaceuticals Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2014-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2014-09-30 was $145.01K.
- Corbus Pharmaceuticals Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2014 was $145.01K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 | $0.00 10-Q · filed 2015-11-10 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $145.01K derived: sum of 2 quarters · filed 2016-03-28 | $145.01K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $145.01K 10-Q · filed 2015-11-10 | $145.01K 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |